Loading company…
PolyPhotonix develops non-invasive photonic medical devices for diabetic retinopathy.
Founded in 2009, PolyPhotonix designs devices to treat and prevent diabetic retinopathy, a condition that can lead to blindness. Its Noctura 400 Sleep Mask delivers light treatment during a patient's normal sleeping hours at home. The company is based in Durham, UK, and is led by CEO Richard Kirk as of 2023. Prevail Partners led a USD 10 million Series A round in January 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in